Literature DB >> 9256343

Krox-20 is a key regulator of rhombomere-specific gene expression in the developing hindbrain.

T Seitanidou1, S Schneider-Maunoury, C Desmarquet, D G Wilkinson, P Charnay.   

Abstract

The morphogenesis of the vertebrate hindbrain involves a transient segmentation process leading to the formation of reiterated organisation units called rhombomeres (r). A number of regulatory genes expressed with a rhombomere-specific pattern have been identified, including the gene encoding the transcription factor Krox-20, which is restricted to r3 and r5. We have previously demonstrated that in r3 and r5 Krox-20 directly controls the transcription of Hoxa-2 and Hoxb-2. In the present study, we provide evidence that Krox-20 is required for the expression of another Hox gene, Hoxb-3, in r5 specifically. Furthermore, the regulatory role of Krox-20 is not restricted to the control of Hox gene expression, since it is also involved in the activation of a receptor tyrosine kinase gene, Sek-1, in r3 and r5 and in the repression of the follistatin gene in r3 but not in r5. In conclusion, at least five regulatory genes belonging to different families are under the direct or indirect control of Krox-20 in r3 and/or r5 and this transcription factor therefore appears as a key regulator of gene expression in the developing hindbrain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256343     DOI: 10.1016/s0925-4773(97)00051-8

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  15 in total

1.  Krox-20 patterns the hindbrain through both cell-autonomous and non cell-autonomous mechanisms.

Authors:  F Giudicelli; E Taillebourg; P Charnay; P Gilardi-Hebenstreit
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

2.  Krox20 and kreisler co-operate in the transcriptional control of segmental expression of Hoxb3 in the developing hindbrain.

Authors:  Miguel Manzanares; Jeannette Nardelli; Pascale Gilardi-Hebenstreit; Heather Marshall; François Giudicelli; María Teresa Martínez-Pastor; Robb Krumlauf; Patrick Charnay
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

3.  T-Box transcription factor Tbx20 regulates a genetic program for cranial motor neuron cell body migration.

Authors:  Mi-Ryoung Song; Ryuichi Shirasaki; Chen-Leng Cai; Esmeralda C Ruiz; Sylvia M Evans; Soo-Kyung Lee; Samuel L Pfaff
Journal:  Development       Date:  2006-12       Impact factor: 6.868

4.  PIASxbeta acts as an activator of Hoxb1 and is antagonized by Krox20 during hindbrain segmentation.

Authors:  Mario Garcia-Dominguez; Pascale Gilardi-Hebenstreit; Patrick Charnay
Journal:  EMBO J       Date:  2006-05-04       Impact factor: 11.598

5.  Krox20 controls the transcription of its various targets in the developing hindbrain according to multiple modes.

Authors:  Anne Desmazières; Patrick Charnay; Pascale Gilardi-Hebenstreit
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

Review 6.  The gene regulatory networks underlying formation of the auditory hindbrain.

Authors:  Marc A Willaredt; Tina Schlüter; Hans Gerd Nothwang
Journal:  Cell Mol Life Sci       Date:  2014-10-21       Impact factor: 9.261

7.  Transcriptome profiling of the cardiac neural crest reveals a critical role for MafB.

Authors:  Saori Tani-Matsuhana; Felipe Monteleone Vieceli; Shashank Gandhi; Kunio Inoue; Marianne E Bronner
Journal:  Dev Biol       Date:  2018-09-17       Impact factor: 3.582

Review 8.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

9.  Novel mutants of NAB corepressors enhance activation by Egr transactivators.

Authors:  J Svaren; B R Sevetson; T Golda; J J Stanton; A H Swirnoff; J Milbrandt
Journal:  EMBO J       Date:  1998-10-15       Impact factor: 11.598

10.  Disruption of Krox20-Nab interaction in the mouse leads to peripheral neuropathy with biphasic evolution.

Authors:  Anne Desmazières; Laurence Decker; Jean-Michel Vallat; Patrick Charnay; Pascale Gilardi-Hebenstreit
Journal:  J Neurosci       Date:  2008-06-04       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.